share_log

君聖泰醫藥-B：截至二零二四年一月三十一日止月份之股份發行人的證券變動月報表

HIGHTIDE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Hong Kong Stock Exchange ·  Feb 5 16:30
Summary by Futu AI
君圣泰医药-B（02511.HK）於2024年2月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年1月31日的公司股份變動情況。報告顯示，公司的法定/註冊股本在該月份未發生變動，上月底結存及本月底結存均為1,000,000,000股，每股面值0.0001美元，法定/註冊股本總額維持在100,000美元。此外，報告中提及的股份期權、權證、可換股票據以及其他相關協議或安排在本月均無變動。公司執行董事兼行政總裁劉利平博士確認，所有證券的發行均已獲得董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
君圣泰医药-B（02511.HK）於2024年2月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年1月31日的公司股份變動情況。報告顯示，公司的法定/註冊股本在該月份未發生變動，上月底結存及本月底結存均為1,000,000,000股，每股面值0.0001美元，法定/註冊股本總額維持在100,000美元。此外，報告中提及的股份期權、權證、可換股票據以及其他相關協議或安排在本月均無變動。公司執行董事兼行政總裁劉利平博士確認，所有證券的發行均已獲得董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
JUN SHENG TAI PHARMACEUTICAL-B (02511.HK) FILED ITS LATEST SECURITIES CHANGE MONTH REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON FEBRUARY 5, 2024, REPORTING CHANGES IN COMPANY SHARES AS OF JANUARY 31, 2024. The report shows that the company's regulated/registered share capital remained unchanged during the month, with 1,000,000,000 shares outstanding at the end of last month and deposits at the end of this month, with a face value of $0.0001 per share, and the total regulated/registered share capital remained at $100,000. IN ADDITION, STOCK OPTIONS, WARRANTS, CONVERTIBLE STOCK NOTES AND OTHER RELATED AGREEMENTS OR ARRANGEMENTS MENTIONED IN THE REPORT WERE UNCHANGED DURING THE MONTH. Dr. Liu Liping, the Executive Director and Chief Executive Officer of the Company, confirmed that all issuance of the securities has been approved by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
JUN SHENG TAI PHARMACEUTICAL-B (02511.HK) FILED ITS LATEST SECURITIES CHANGE MONTH REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON FEBRUARY 5, 2024, REPORTING CHANGES IN COMPANY SHARES AS OF JANUARY 31, 2024. The report shows that the company's regulated/registered share capital remained unchanged during the month, with 1,000,000,000 shares outstanding at the end of last month and deposits at the end of this month, with a face value of $0.0001 per share, and the total regulated/registered share capital remained at $100,000. IN ADDITION, STOCK OPTIONS, WARRANTS, CONVERTIBLE STOCK NOTES AND OTHER RELATED AGREEMENTS OR ARRANGEMENTS MENTIONED IN THE REPORT WERE UNCHANGED DURING THE MONTH. Dr. Liu Liping, the Executive Director and Chief Executive Officer of the Company, confirmed that all issuance of the securities has been approved by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.